Gartisertib
Product Specifications
UNSPSC Description
Gartisertib (VX-803) is an ATP-competitive, orally active, and selective ATR inhibitor, with a Ki of 50 of 8 nM. Antitumor activity[1][2].
Target Antigen
ATM/ATR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;PI3K/Akt/mTOR
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/atr-inhibitor-2.html
Smiles
O=C(C1=C2N=CC(F)=CN2N=C1N)NC3=C(N4CCC(C(N5CCN(C6COC6)CC5)=O)CC4)C(F)=CN=C3
Molecular Weight
541.55
References & Citations
[1]Frank T. Zenke, et al. Abstract 369: Antitumor activity of M4344, a potent and selective ATR inhibitor, in monotherapy and combination therapy. Experimental and Molecular Therapeutics.|[2]Gorecki L, et al. Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy. Pharmacol Ther. 2020 Feb 26:107518.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-136270/Gartisertib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-136270/Gartisertib-SDS-MedChemExpress.pdf
CAS Number
1613191-99-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1263654-01 1 mg (E-Coli)
Recombinant Crucihimalaya wallichii Photosystem II reaction center protein L (psbL), partial
Ask
View Details 
MBS1263654-02 1 mg (Yeast)
Recombinant Crucihimalaya wallichii Photosystem II reaction center protein L (psbL), partial
Ask
View Details MBS1493654-01 0.05 mL
Rabbit anti-human E3 ubiquitin-protein ligase CBL-C polyclonal Antibody(CBLC)
Ask
View Details